Offergeld, R.;                     Preußel, K.;                     Zeiler, T.;                     Aurich, K.;                     Baumann-Baretti, B.I.;                     Ciesek, S.;                     Corman, V.M.;                     Dienst, V.;                     Drosten, C.;                     Görg, S.;     
    et al.    Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany—Results from the SeBluCo Study 2020–2022. Pathogens 2023, 12, 551.
    https://doi.org/10.3390/pathogens12040551
    AMA Style
    
                                Offergeld R,                                 Preußel K,                                 Zeiler T,                                 Aurich K,                                 Baumann-Baretti BI,                                 Ciesek S,                                 Corman VM,                                 Dienst V,                                 Drosten C,                                 Görg S,         
        et al.        Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany—Results from the SeBluCo Study 2020–2022. Pathogens. 2023; 12(4):551.
        https://doi.org/10.3390/pathogens12040551
    
    Chicago/Turabian Style
    
                                Offergeld, Ruth,                                 Karina Preußel,                                 Thomas Zeiler,                                 Konstanze Aurich,                                 Barbara I. Baumann-Baretti,                                 Sandra Ciesek,                                 Victor M. Corman,                                 Viktoria Dienst,                                 Christian Drosten,                                 Siegfried Görg,         
         and et al.        2023. "Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany—Results from the SeBluCo Study 2020–2022" Pathogens 12, no. 4: 551.
        https://doi.org/10.3390/pathogens12040551
    
    APA Style
    
                                Offergeld, R.,                                 Preußel, K.,                                 Zeiler, T.,                                 Aurich, K.,                                 Baumann-Baretti, B. I.,                                 Ciesek, S.,                                 Corman, V. M.,                                 Dienst, V.,                                 Drosten, C.,                                 Görg, S.,                                 Greinacher, A.,                                 Grossegesse, M.,                                 Haller, S.,                                 Heuft, H.-G.,                                 Hofmann, N.,                                 Horn, P. A.,                                 Houareau, C.,                                 Gülec, I.,                                 Jiménez Klingberg, C. L.,         
                                            ... der Heiden, M. a.        
        (2023). Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany—Results from the SeBluCo Study 2020–2022. Pathogens, 12(4), 551.
        https://doi.org/10.3390/pathogens12040551